Sign up for email alert when new content gets added: Sign up
Background: Parkinson’s disease (PD) is a neurodegenerative disorder with growing prevalence, age-standardised death rates and disability. Recent expansions in cannabis legalization have revived interest in therapeutic applications of medical cannabis and its derivatives (MC) in PD. Our team previously conducted a systematic review and meta-analysis on the use of MC in PD patients to determine its effect on motor function and its safety profile.
Journal of Clinical Psychiatry and Neuroscience received 36 citations as per Google Scholar report
Top
+447723598358